We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
A comprehensive guide for Indian patients on Udenyca side effects, covering common and serious reactions, management strategies, and when to seek medical help.
Udenyca, a biosimilar medication containing the active ingredient pegfilgrastim-cbqv, plays a crucial role in supporting patients undergoing chemotherapy. Its primary function is to stimulate the production of white blood cells, thereby helping to prevent infections in individuals with certain types of cancer, specifically non-myeloid cancers. While Udenyca is a valuable tool in cancer treatment, like all medications, it can present a range of side effects, from mild to severe. This guide aims to provide clear, practical information for Indian patients about the potential side effects of Udenyca, how to manage them, and when to seek immediate medical attention.
Udenyca is prescribed to adults and children who are receiving chemotherapy for non-myeloid cancers. Non-myeloid cancer refers to cancers that do not affect the bone marrow. Chemotherapy, while effective in fighting cancer cells, often suppresses the immune system by reducing the number of white blood cells. This makes patients highly susceptible to infections, which can be life-threatening. Udenyca works by signaling the bone marrow to produce more white blood cells, bolstering the immune system's ability to fight off infections during and after chemotherapy.
The medication is administered as an injection under the skin, typically using a prefilled syringe. The duration of Udenyca treatment is usually aligned with the chemotherapy regimen or the period of increased infection risk.
While serious side effects are rare, it's important to be aware of the more common, often milder, side effects associated with Udenyca. These can typically be managed with medical guidance.
One of the most frequently reported side effects of Udenyca is pain in the arms, hands, legs, or feet. This discomfort can range from mild to moderate and may be related to the medication's effect on bone marrow and white blood cell production.
Other mild side effects that some patients might experience include:
These mild side effects are usually temporary and tend to resolve on their own. However, if any of these symptoms are persistent, bothersome, or interfere with daily activities, it is essential to consult your doctor or pharmacist. Do not stop taking Udenyca without consulting your healthcare provider.
Although less common, Udenyca can cause serious side effects that require immediate medical attention. Recognizing these symptoms early is crucial for prompt and effective treatment.
ARDS is a severe lung condition characterized by sudden and widespread inflammation in the lungs. Symptoms can include:
Action: ARDS is a medical emergency. If you experience any symptoms suggestive of ARDS during your Udenyca treatment, call emergency services (like 108 or 112 in India) or go to the nearest emergency room immediately.
The spleen is an organ that filters blood. In rare cases, Udenyca can cause the spleen to enlarge and potentially rupture, which is a life-threatening condition. Symptoms of a ruptured spleen include:
Action: If you suspect a ruptured spleen, call emergency services or go to the nearest emergency room without delay.
Allergic reactions can occur with any medication. Symptoms of a severe allergic reaction to Udenyca may include:
Action: If you experience any signs of a severe allergic reaction, call emergency services or your local emergency number immediately. These reactions can be life-threatening and require urgent medical care.
Udenyca is designed to increase white blood cell counts. However, sometimes this increase can be excessively high, a condition known as leukocytosis. While often asymptomatic, very high levels can sometimes be associated with other complications. Your doctor will monitor your blood counts regularly.
This is a group of kidney disorders that affect the small blood vessels in the kidneys, impairing their ability to filter waste from the blood. Symptoms can include:
Action: If you notice any signs of kidney problems, inform your doctor promptly.
In rare instances, long-term use of medications that stimulate white blood cell production has been associated with an increased risk of developing certain blood or bone marrow cancers, such as myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). This risk is generally considered in the context of the underlying cancer being treated.
This is a rare but serious condition where fluid and proteins leak out of tiny blood vessels (capillaries) into surrounding tissues. Symptoms can include:
Action: Seek immediate medical attention if you experience symptoms of capillary leak syndrome.
It is essential to maintain open communication with your healthcare team throughout your Udenyca treatment. You should contact your doctor immediately if you experience:
Emergency Situations: In case of life-threatening symptoms like severe shortness of breath, chest pain, sudden severe headache, or signs of a ruptured spleen or severe allergic reaction, do not hesitate to call emergency services (108/112) or go to the nearest hospital emergency room immediately.
Effective management of Udenyca side effects involves a combination of medical advice and self-care strategies:
While Udenyca is prescribed to prevent infection, certain precautions can further minimize risks:
While most side effects are temporary, rare serious side effects like blood cancers or kidney issues can have long-term implications. Close monitoring by your doctor is essential. The benefits of preventing life-threatening infections during chemotherapy often outweigh the potential risks.
The duration of pain can vary among individuals. For some, it may resolve within a few days, while for others, it might persist as long as they are on treatment. Discuss persistent pain with your doctor for appropriate management.
Generally, over-the-counter pain relievers like paracetamol are safe. However, always consult your doctor or pharmacist before taking any new medication, including over-the-counter drugs, to avoid potential interactions.
Udenyca is typically given as a single injection per chemotherapy cycle. If you miss an appointment or have concerns about your dosage schedule, contact your doctor or clinic immediately to reschedule or discuss the plan.
Yes, Udenyca can be prescribed for children receiving chemotherapy for non-myeloid cancer, under the guidance of a pediatrician or oncologist.
Disclaimer: This information is intended for educational purposes and should not be considered medical advice. Always consult with your healthcare provider for any health concerns or before making any decisions related to your treatment.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026